Perspective Therapeutics, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2023 - Q4(Jul 23 · Aug 23 · Sep 23)
Total Assets
$267M
↓-21.7% -$74Mvs FY2024
Total Liabilities
$60M
↑+18.9% +$10Mvs FY2024
Equity
$207M
↓-28.8% -$84Mvs FY2024
Cash
$31M
↓-50.3% -$31Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $267M | $341M |
| Current Assets | $148M | $231M |
| Cash | $31M | $62M |
| ST Investments | $114M | $165M |
| Receivables | $6K | $116K |
| Inventory | $0 | $0 |
| Other Current | $4M | $4M |
| Non-Current Assets | $119M | $110M |
| PPE | $77M | $57M |
| Goodwill | $0 | $0 |
| Intangibles | $362K | $279K |
| Investments | $0 | $0 |
| Other Non-Current | $42M | $52M |
| Total Liab+Eq | $267M | $341M |
| Current Liab. | $29M | $18M |
| Accounts Payable | $0 | $0 |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $29M | $18M |
| Non-Current Liab. | $31M | $32M |
| Long-Term Debt | $2M | $2M |
| Other LT Liab. | $30M | $31M |
| Equity | $207M | $291M |
| Retained Earnings | $335M | $232M |
| Other Equity | $0 | $59M |
QuarterCharts · SEC EDGAR data · CATX · Comparing FY2025 vs FY2024